were down more than 12% in premarket trading after the company swung to a fiscal third-quarter loss despite soaring revenue. "I am proud of the efforts of our over 1,000 employees worldwide as we continue to position Aphria for future growth and success in the global medical and adult-use cannabis industry," stated Irwin D. Simon, Aphria's chairman and interim CEO.